Clinical Trial Update: Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 trial comparing bolus versus prolonged infusion of meropenem in newborns with late-onset sepsis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Neonatal Sepsis

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: Mansoura University | Conditions: Late Onset Neonatal Sepsis | Phase 3 | Status: COMPLETED